Tuesday, 02 January 2024 12:17 GMT

U.S. Employer And Workplace Drug Testing (Pre-, Post-Employment) Market Size, Share & Trends Analysis Report 2025-2033


(MENAFN- GlobeNewsWire - Nasdaq) The U.S. employer and workplace drug testing market offers opportunities driven by stringent safety regulations, rising substance misuse awareness, and evolving cannabis laws. Innovations in testing methods and digital results enhance compliance and efficiency. These trends support market growth in diverse industries.

Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "U.S. Employer and Workplace Drug Testing Market Size, Share & Trends Analysis Report by Type (Pre-employment Drug Screens, Post-employment), by Product, by Mode, by Drug, by End-use (IT/Finance, Manufacturing), and Segment Forecasts, 2025-2033" has been added to ResearchAndMarkets's offering.

The U.S. employer and workplace drug testing market is projected to grow from an estimated USD 2.57 billion in 2024 to USD 4.01 billion by 2033, reflecting a CAGR of 5.2% from 2025 to 2033.

This growth is driven by stringent workplace safety regulations, heightened awareness of substance abuse risks, and the increasing adoption of preventive screening measures across industries. Drug testing programs are critical for detecting illicit substances and are integral in adhering to federal and state regulations, enhancing productivity, and minimizing workplace incidents.

The demand for both pre-employment and random workplace testing solutions is increasing, bolstered by advancements in rapid testing kits, lab tests, and oral fluid testing methods. The integration of digital result systems and automated reporting has expedited the testing process, enabling quicker hiring decisions and more effective staff monitoring. Additionally, shifting cannabis laws in several states necessitate policy adaptations to ensure legal compliance.

Research by American Addiction Centers in 2024 revealed that 15.3% of U.S. workers have been under the influence of alcohol while on the job, with 2.9% admitting to drug use. These figures stress the persistent challenges employers face and underscore the necessity for robust drug testing policies to safeguard workplace safety and sustain productivity.

Substance use disorders among employees further emphasize the relevance of workplace testing. Such issues lead to reduced productivity, increased absenteeism, and higher incidences of illness, consequently affecting employee morale and elevating the likelihood of workplace accidents and injuries, collectively costing U.S. businesses billions annually. These elements are projected to continue fueling the demand for drug testing services nationally.

The sector is experiencing continuous innovation aimed at enhancing speed, accuracy, and user-friendliness. Developments in testing techniques, digital results management, and analytical tools are streamlining screening processes while ensuring alignment with evolving regulations. Adopting multi-panel and oral fluid testing, with support from cloud-based platforms and AI-driven analytics, is facilitating the detection of a broader range of substances and early identification of potential concerns. These advancements are poised to bolster workplace safety programs and optimize workforce management in the future.

Key Attributes:

Report Attribute Details
No. of Pages 150
Forecast Period 2024 - 2033
Estimated Market Value (USD) in 2024 $2.57 Billion
Forecasted Market Value (USD) by 2033 $4.01 Billion
Compound Annual Growth Rate 5.2%
Regions Covered United States


U.S. Employer and Workplace Drug Testing Market Report Segmentation:

  • Type Outlook (Revenue in USD Million, 2021-2033): Pre-employment Drug Screens, Post-employment
  • Product Outlook (Revenue in USD Million, 2021-2033): Consumables, Instruments, Rapid Testing Devices, Services
  • Mode Outlook (Revenue in USD Million, 2021-2033): Consumables, Instruments, Rapid Testing Devices, Services
  • Drug Outlook (Revenue in USD Million, 2021-2033): Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Others
  • End-use Outlook (Revenue in USD Million, 2021-2033): IT/Finance, Manufacturing, Transportation, Construction, Retail and Hospitality, Healthcare, Education, Other Professional Services

Companies Featured

  • First Advantage
  • Laboratory Corporation of America Holdings (Labcorp)
  • Dragerwerk AG & Co. KGaA
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Clinical Reference Laboratory Inc.
  • Quest Diagnostics
  • Cordant Health Solutions
  • DISA Global Solutions
  • HireRight, LLC
  • OraSure Technologies, Inc.
  • Omega Laboratories
  • Psychemedics Corporation

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

  • U.S. Employer and Workplace Drug Testing Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN26092025004107003653ID1110115034

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search